Loblaw on Thursday posted $33.6 billion in revenue for its year ended Jan. 2, a 6.5% lift with one week less of sales - Loblaw's fiscal 2015 represents 52 weeks while fiscal 2014 represents 53 weeks.
"I am pleased to report that we continued to deliver against our financial plan in the fourth quarter," stated Galen Weston, executive chairman and president, Loblaw. "The company continues to execute on its strategic framework and purpose of Live Life Well - consistently delivering the best in food, best in health and beauty, operational excellence and growth. Our relentless focus on this framework has positioned us to achieve our financial plan amidst a competitive environment and continued pressures from healthcare reform."
For the fourth quarter, Loblaw's retail pharmacy arm Shoppers Drug Mart realized same-store sales growth of 5%, with same-store pharmacy sales increasing by 4.2% and same-store front-store sales increasing by 5.7%.
Total sales across Shoppers Drug Mart for the quarter were $2.2 billion, with $972.5 million in pharmacy sales and $1.2 billion in front-end sales.